Articles

There are common genetic factors that slightly predispose individuals to develop both periodontal disease and cardiovascular disease, a prospective study of Swedish twins indicates.

Exsulin Corporation announces next hase II trial of novel islet regeneration treatment in Type 1 diabetes. Leading diabetes research centers collaborate on new trial designed to further evaluate regeneration treatment for people with Type 1 diabetes.

New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study.

Expression of the tumor suppressor gene p53 in adipose tissue plays a key role in the development of insulin resistance, new studies in mice and humans reveal.

A computer-aided insulin infusion protocol maintains glucose control in the ICU as effectively as a strict glycemic control protocol, and both of these methods are more effective than conventional treatment, researchers report.

Compared with white patients, black patients who have an in-hospital cardiac arrest are significantly less likely to survive to hospital discharge, having lower rates of successful resuscitation and postresuscitation survival, although much of this survival difference was associated with the hospital in which black patients received care, according to a …

JDRF funded researchers have today added to the evidence that using a continuous glucose monitoring (CGM) device can improve diabetes control.

Diamyd Medical announced last week that the company’s 4-year follow-up of Type 1 diabetes patients included in the company’s Phase II study shows a clear positive trend.

This new device, now available in more than 50 countries outside of the United States, can automatically suspend insulin delivery when the device senses that glucose levels have fallen to or below a user-selected threshold.

Effects on weight loss, insulin resistance and cardiovascular risk: a randomised control trial.